Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluating a Technology-augmented Self-monitoring Model for Glycemic and Blood Pressure Control and Medication Adherence in Type 2 Diabetes and Hypertension Patients: a Randomized Controlled Trial
Brief Summary: Objective: To develop and evaluate a technology-augmented self-monitoring model using a randomized controlled trial to demonstrate whether patients with co-morbid type 2 diabetes mellitus and hypertension can improve their glycemic and blood pressure control, adherence to medication regimens, and other relevant outcomes by using a tablet-based consumer health information technology (CHIT) to support the self-monitoring and self-management of their chronic conditions.

Design: A two-group, randomized controlled trial with follow-up assessments 8, 12, 16, and 24 weeks after the baseline evaluation.

Setting: Patients' homes.

Participants: Two hundred and ninety-six adult patients with type 2 diabetes mellitus and hypertension who receive their health care from a local community health service network or a major hospital will be recruited.

Interventions: Participants in the technology-augmented self-monitoring model (intervention group) will use a tablet-based, interactive touch screen self-monitoring system to monitor and manage their chronic conditions. The system is designed to augment patients' abilities to assess, record, and review their health signs while providing text-, audio-, and video-based resources supporting disease self-care. The participants in the usual-care group will perform conventional self-monitoring.

Outcome measures: The primary outcomes will be glycemic control measured by changes in HbA1c,blood pressure control assessed by changes in systolic and diastolic blood pressure, and medication compliance. The secondary outcomes will be adherence to diabetes and hypertension self-care activities and knowledge of diabetes and hypertension.

Implication: This study will improve our understanding of the clinical value of CHITs in chronic disease self-monitoring and self-management.


Options:
A: Arm Label: Behavioral; Type: EXPERIMENTAL; Interventions: Behavioral: Community Health Worker home visits | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Community Health Worker home visits | Intervention Type: BEHAVIORAL; Name: Community Health Worker home visits; Assigned to Arm(s): Behavioral, Usual Care
B: Arm Label: Geriatric Diabetes Team Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral | Arm Label: Atention Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral; Assigned to Arm(s): Geriatric Diabetes Team Intervention
C: Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Behavioral: Telemedicine | Arm Label: Standard treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Telemedicine; Assigned to Arm(s): Telemedicine
D: Arm Label: Technology-based self-management model; Type: EXPERIMENTAL; Interventions: Device: Technology-based self-management model | Arm Label: Conventional self-management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Technology-based self-management model; Assigned to Arm(s): Technology-based self-management model

Answer: D